Related Experiment Video
Updated: May 19, 2026

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Enhanced binding of calmodulin to the ryanodine receptor corrects contractile dysfunction in failing hearts
Akihiro Hino1, Masafumi Yano, Takayoshi Kato
1Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi 755-8505, Japan.
Aims:
The channel function of the cardiac ryanodine receptor (RyR2) is modulated by calmodulin (CaM). However, the involvement of CaM in aberrant Ca(2+) release in diseased hearts remains unclear. Here, we investigated the pathogenic role of defective CaM binding to the RyR2 in the channel dysfunction associated with heart failure.
Methods And Results:
The involvement of CaM in aberrant Ca(2+) release was assessed in normal and pacing-induced failing canine hearts. The apparent affinity of CaM for RyR2 was considerably lower in failing sarcoplasmic reticulum (SR) compared with normal SR. Thus, the amount of CaM bound to RyR2 was markedly decreased in failing myocytes. Expression of the CaM isoform Gly-Ser-His-CaM (GSH-CaM), which has much higher binding affinity than wild-type CaM for RyR1, restored normal CaM binding to RyR2 in both SR and myocytes of failing hearts. The Ca(2+) spark frequency (SpF) was markedly higher and the SR Ca(2+) content was lower in failing myocytes compared with normal myocytes. The incorporation of GSH-CaM into the failing myocytes corrected the aberrant SpF and SR Ca(2+) content to normal levels.
Conclusion:
Reduced CaM binding to RyR2 seems to play a critical role in the pathogenesis of aberrant Ca(2+) release in failing hearts. Correction of the reduced CaM binding to RyR2 stabilizes the RyR2 channel function and thereby restores normal Ca(2+) handling and contractile function to failing hearts.
Insights
Reduced calmodulin (CaM) binding to the cardiac ryanodine receptor (RyR2) contributes to heart failure by causing abnormal calcium release. Restoring CaM binding to RyR2 normalizes channel function and improves heart contractility.
Area of Science:
- Cardiovascular Physiology
- Molecular Cardiology
- Calcium Signaling
Background:
- Cardiac ryanodine receptor (RyR2) function is modulated by calmodulin (CaM).
- The role of CaM in abnormal calcium release during heart failure is not fully understood.
Purpose of the Study:
- To investigate the pathogenic role of defective CaM binding to RyR2 in heart failure-associated channel dysfunction.
- To explore the therapeutic potential of enhancing CaM binding to RyR2.
Main Methods:
- Assessed CaM involvement in aberrant calcium release in normal and failing canine hearts.
- Utilized the CaM isoform Gly-Ser-His-CaM (GSH-CaM) to restore CaM binding to RyR2.
- Measured calcium spark frequency (SpF) and sarcoplasmic reticulum (SR) Ca(2+) content in myocytes.
Main Results:
- CaM binding affinity to RyR2 was significantly lower in failing hearts.
- Failing myocytes exhibited increased SpF and reduced SR Ca(2+) content.
- GSH-CaM expression corrected aberrant SpF and SR Ca(2+) content in failing myocytes.
Conclusions:
- Reduced CaM binding to RyR2 is critical in the pathogenesis of aberrant calcium release in heart failure.
- Restoring CaM binding to RyR2 stabilizes channel function, normalizing calcium handling and contractile function.
More Related Videos
Related Concept Videos
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Smooth Muscle Contraction
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
Heart Failure Drugs: Inotropic Agents
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy

